Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Inhibition of mitochondrial -oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo
*Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality.
This page provides general information only and does not make specific medicinal, cosmetic, or therapeutic claims
Contribution statement JIM contributed to the design of the study, constructed the model, performed the analysis and literature search, acquisition and interpretation of the data, and wrote and revised the manuscript
US$ 27.04
US$ 27.83
US$ 23.66
